Glucagon-like peptide receptor agonists and risk for depression
Primary Care Diabetes · 2024
DOI: 10.1016/j.pcd.2024.05.005 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Primary Care Diabetes, 2024. Verfasst von Gabriella A Tagliapietra und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Services, Iowa City Veterans Affairs Health Care System, 601 Highway 6 West, Iowa City, IA 52246, USA. Hauptthemen laut MEDLINE: Depression, Hypoglycemic Agents, Glucagon-Like Peptide-1 Receptor Agonists. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: Department of Veteran Affairs, Health Services Research and Development, U.S. Department of Veterans Affairs.
Themen: Depression
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy Services, Iowa City Veterans Affairs Health Care System, 601 Highway 6 West, Iowa City, IA 52246, USA.
- Department of Pharmacy Services, Iowa City Veterans Affairs Health Care System, 601 Highway 6 West, Iowa City, IA 52246, USA; Center for Access & Delivery Research and Evaluation, Iowa City Veterans Affairs Health Care…
Förderung
- Department of Veteran Affairs
- Health Services Research and Development
- U.S. Department of Veterans Affairs
Zitieren
APA
Tagliapietra, G. A., Cantrell, M. A., & Lund, B. C. (2024). Glucagon-like peptide receptor agonists and risk for depression. Primary Care Diabetes. https://doi.org/10.1016/j.pcd.2024.05.005
Vancouver
Tagliapietra GA, Cantrell MA, Lund BC. Glucagon-like peptide receptor agonists and risk for depression. Primary Care Diabetes. 2024. doi:10.1016/j.pcd.2024.05.005
BibTeX
@article{Tagliapietra2024,
author = {Tagliapietra, Gabriella A and Cantrell, Matthew A and Lund, Brian C},
title = {Glucagon-like peptide receptor agonists and risk for depression},
journal = {Primary Care Diabetes},
year = {2024},
doi = {10.1016/j.pcd.2024.05.005}
}
EUVIMED